Literature DB >> 22614018

Promotion of DNA repair by nuclear IKKβ phosphorylation of ATM in response to genotoxic stimuli.

K Sakamoto1, Y Hikiba, H Nakagawa, Y Hirata, Y Hayakawa, H Kinoshita, W Nakata, K Sakitani, R Takahashi, M Akanuma, H Kamata, S Maeda.   

Abstract

Ataxia-telangiectasia mutated (ATM) is one of the key molecules involved in the cellular response to DNA damage. A portion of activated ATM is exported from the nucleus into the cytoplasm, where it activates the I kappa B kinase/nuclear factor kappa B (IKK/NF-κB) signaling pathway. It has been thought that activated IKKβ, which is a critical kinase for NF-κB activation, generally resides in the cytoplasm and phosphorylates cytoplasmic downstream molecules, such as IκBα. Here, we identified a new role for IKKβ during the response to DNA damage. ATM phosphorylation in response to alkylating agents consisted of two phases: the early phase (up to 3 h) and late phase (after 6 h). A portion of the activated IKKβ generated during the DNA damage response was found to translocate into the nucleus and directly phosphorylate ATM in the late phase. Furthermore, the phosphorylation of ATM by nuclear IKKβ was suggested to promote DNA repair. In parallel, activated IKKβ induced classical NF-κB activation and was involved in anti-apoptosis. Our findings define the function of IKKβ during the response to DNA damage, which promotes cell survival and DNA repair, and maintains cellular homeostasis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22614018     DOI: 10.1038/onc.2012.192

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  Proteasome inhibition increases recruitment of IκB kinase β (IKKβ), S536P-p65, and transcription factor EGR1 to interleukin-8 (IL-8) promoter, resulting in increased IL-8 production in ovarian cancer cells.

Authors:  Bipradeb Singha; Himavanth Reddy Gatla; Subrata Manna; Tzu-Pei Chang; Shannon Sanacora; Vladimir Poltoratsky; Ales Vancura; Ivana Vancurova
Journal:  J Biol Chem       Date:  2013-12-11       Impact factor: 5.157

2.  Inhibiting WEE1 and IKK-RELA Crosstalk Overcomes TNFα Resistance in Head and Neck Cancers.

Authors:  Carter Van Waes; Ethan L Morgan; Zhengbo Hu; Ramya Viswanathan; Hui Cheng; Jianghong Chen; Xinping Yang; Angel Huynh; Paul Clavijo; Yi An; Yvette Robbins; Christopher Silvin; Clint Allen; Pinar Ormanoglu; Scott Martin; Shaleeka Cornelius; Anthony Saleh; Zhong Chen
Journal:  Mol Cancer Res       Date:  2022-06-03       Impact factor: 6.333

3.  Regulation of anoikis by deleted in breast cancer-1 (DBC1) through NF-κB.

Authors:  Sun Hee Park; Philip Riley; Steven M Frisch
Journal:  Apoptosis       Date:  2013-08       Impact factor: 4.677

4.  A novel pVHL-independent but NEMO-driven pathway in renal cancer promotes HIF stabilization.

Authors:  A M Nowicka; I Häuselmann; L Borsig; S Bolduan; M Schindler; P Schraml; M Heikenwalder; H Moch
Journal:  Oncogene       Date:  2015-10-26       Impact factor: 9.867

5.  A quasi-quantitative dual multiplexed immunoblot method to simultaneously analyze ATM and H2AX Phosphorylation in human peripheral blood mononuclear cells.

Authors:  Christopher J Bakkenist; R Kenneth Czambel; Pamela A Hershberger; Hussein Tawbi; Jan H Beumer; John C Schmitz
Journal:  Oncoscience       Date:  2015-05-14

6.  Functional analyses of ATM, ATR and Fanconi anemia proteins in lung carcinoma : ATM, ATR and FA in lung carcinoma.

Authors:  Jan H Beumer; Katherine Y Fu; Bean N Anyang; Jill M Siegfried; Christopher J Bakkenist
Journal:  BMC Cancer       Date:  2015-10-05       Impact factor: 4.430

Review 7.  New approaches to radiation protection.

Authors:  Eliot M Rosen; Regina Day; Vijay K Singh
Journal:  Front Oncol       Date:  2015-01-20       Impact factor: 6.244

Review 8.  Context-Dependent Role of IKKβ in Cancer.

Authors:  Angustias Page; Manuel Navarro; Cristian Suárez-Cabrera; Ana Bravo; Angel Ramirez
Journal:  Genes (Basel)       Date:  2017-12-08       Impact factor: 4.096

9.  Paeonol attenuates inflammation by targeting HMGB1 through upregulating miR-339-5p.

Authors:  Liyan Mei; Meihong He; Chaoying Zhang; Jifei Miao; Quan Wen; Xia Liu; Qin Xu; Sen Ye; Peng Ye; Huina Huang; Junli Lin; Xiaojing Zhou; Kai Zhao; Dongfeng Chen; Jianhong Zhou; Chun Li; Hui Li
Journal:  Sci Rep       Date:  2019-12-18       Impact factor: 4.379

10.  MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance.

Authors:  Dawid Mehlich; Michał Łomiak; Aleksandra Sobiborowicz; Alicja Mazan; Dagmara Dymerska; Łukasz M Szewczyk; Anna Mehlich; Agnieszka Borowiec; Monika K Prełowska; Adam Gorczyński; Paweł Jabłoński; Ewa Iżycka-Świeszewska; Dominika Nowis; Anna A Marusiak
Journal:  Cell Death Dis       Date:  2021-11-27       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.